{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:48:00Z","timestamp":1763016480443,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3935,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.bbmt.2004.03.002","type":"journal-article","created":{"date-parts":[[2004,6,17]],"date-time":"2004-06-17T07:28:38Z","timestamp":1087457318000},"page":"484-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced"],"prefix":"10.1016","volume":"10","author":[{"given":"Avichai","family":"Shimoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Yeshurun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izhar","family":"Hardan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Avigdor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Ben-Bassat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2004.03.002_BIB1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-196603000-00003","article-title":"Thrombotic thrombocytopenic purpura","volume":"45","author":"Amorosi","year":"1966","journal-title":"Medicine."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB3","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1182\/blood-2002-07-2241","article-title":"Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura","volume":"100","author":"Tsai","year":"2002","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB4","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB5","first-page":"495","article-title":"Thrombotic microangiopathy following bone marrow transplantation","volume":"14","author":"Pettitt","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB6","first-page":"126","article-title":"Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"34","author":"Schriber","year":"1997","journal-title":"Semin Hematol."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4065\/78.4.421","article-title":"Posttransplantation thrombotic thrombocytopenic purpura","volume":"78","author":"Elliott","year":"2003","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1046\/j.1365-2141.2002.03721.x","article-title":"Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation","volume":"118","author":"Ruutu","year":"2002","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.02699.x","article-title":"The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation","volume":"113","author":"Fuge","year":"2001","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/sj.bmt.1701890","article-title":"Thrombotic microangiopathy following allogeneic bone marrow transplantation","volume":"24","author":"Takatsuka","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.bmt.1702648","article-title":"Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation","volume":"26","author":"Uderzo","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bmt.1702849","article-title":"Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation","volume":"27","author":"Roy","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.bmt.1701359","article-title":"Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis","volume":"22","author":"Paquette","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1701830","article-title":"Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"24","author":"Iacopino","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB15","first-page":"247","article-title":"Bone marrow transplant-associated thrombotic microangiopathy","volume":"15","author":"Zeigler","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00007890-199511000-00012","article-title":"Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis","volume":"60","author":"Kalhs","year":"1995","journal-title":"Transplantation."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB17","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1080\/1042819021000015862","article-title":"Thrombotic thrombocytopenic purpura following stem cell transplantation","volume":"43","author":"Allford","year":"2002","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB18","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood.V93.11.3798","article-title":"von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura","volume":"93","author":"van der Plas","year":"1999","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB20","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood.V73.7.2018.2018","article-title":"Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation","volume":"73","author":"Holler","year":"1989","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB21","first-page":"271","article-title":"Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome following bone marrow transplantation","volume":"16","author":"Sarode","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00007890-198710000-00022","article-title":"Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation\u2014successful treatment with plasma exchange","volume":"44","author":"Dzik","year":"1987","journal-title":"Transplantation."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB23","first-page":"455","article-title":"Cyclosporin-induced endothelial cell injury","volume":"55","author":"Zoja","year":"1986","journal-title":"Lab Invest."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB25","first-page":"18","article-title":"Harnessing graft-versus-malignancy","volume":"111","author":"Champlin","year":"2000","journal-title":"Br J Haematol."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB26","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/sj.leu.2402316","article-title":"Non-myeloablative stem cell transplantation (NST)","volume":"15","author":"Shimoni","year":"2001","journal-title":"Leukemia."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1182\/blood.V96.4.1223","article-title":"How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"96","author":"George","year":"2000","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF02983218","article-title":"Clinical significance of fragmented red cells after allogeneic bone marrow transplantation","volume":"77","author":"Kanamori","year":"2003","journal-title":"Int J Hematol."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB30","first-page":"205","article-title":"Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) \u00b1 TBI and autologous BMT for malignant lymphomas","volume":"11","author":"Carlson","year":"1993","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB31","first-page":"339","article-title":"Haemolytic uraemic syndrome after bone marrow transplantation","volume":"3","author":"Chappell","year":"1988","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood.V99.1.75","article-title":"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies","volume":"99","author":"Corradini","year":"2002","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1702518","article-title":"Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease","volume":"26","author":"van Besien","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB34","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1182\/blood.V80.12.2964.2964","article-title":"Cytokine dysregulation and acute graft-versus-host disease","volume":"80","author":"Antin","year":"1992","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","article-title":"Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation","volume":"102","author":"Mielcarek","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB36","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1182\/blood.V100.1.334","article-title":"Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells","volume":"100","author":"Eissner","year":"2002","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB37","first-page":"737","article-title":"Treatment of severe veno-occlusive disease with defibrotide","volume":"92","author":"Richardson","year":"1998","journal-title":"Blood."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.bmt.1701472","article-title":"Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses","volume":"22","author":"Milone","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jca.10008","article-title":"Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation","volume":"16","author":"Teruya","year":"2001","journal-title":"J Clin Apheresis."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000046558","article-title":"Plasmapheresis for thrombotic thrombocytopenic purpura following bone marrow transplantation","volume":"105","author":"Kolker","year":"2001","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB42","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0301-472X(03)00047-X","article-title":"Intravenous busulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation","volume":"31","author":"Shimoni","year":"2003","journal-title":"Exp Hematol."},{"key":"10.1016\/j.bbmt.2004.03.002_BIB43","first-page":"863","article-title":"Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation","volume":"15","author":"Srivastava","year":"1995","journal-title":"Bone Marrow Transplant."}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104001119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104001119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:21:10Z","timestamp":1761056470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879104001119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1083879104001119"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.03.002","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}